Objective To discuss the effect of inhaled nitric oxide (iNO) therapy in neonatal persistent pulmonary hypertension(PPHN).
目的探讨一氧化氮（NO）吸入疗法治疗新生儿持续肺动脉高压（PPHN）的疗效。
Magnesium sulfate is a potent vasodilator and hence has the potential to reduce the high pulmonary arterial pressures associated with PPHN.
硫酸镁是一种强有力的血管扩张剂，因此具有降低因新生儿持续性肺高压造成之肺动脉高压的潜能。
If magnesium sulfate were found to be effective in the treatment of PPHN, this could be a cost effective and potentially life-saving therapy.
倘若硫酸镁能被证实可以有效地治疗新生儿持续性肺高压，则这就会成为一种符合经济效益又有可能抢救生命的治疗。
Persistent pulmonary hypertension of the newborn (PPHN) occurs in approximately 1.9 per 1000 newborns and may be more frequent in developing countries.
平均每1000名新生儿中就会有1.9个有新生儿持续性肺高压，在开发中国家则可能会更频繁。
Objective: To evaluate the value of echocardiography (echo) on the diagnosis and the therapeutic observation of persistent pulmonary hypertension of the neonate (PPHN).
目的：探讨超声心动图对新生儿持续肺动脉高压的诊断及临床疗效观察价值。
On the basis of the current lack of evidence, the use of magnesium sulphate cannot be recommended in the treatment of PPHN. Randomised controlled trials are recommended.
由于目前缺乏证据，并不推荐使用硫酸镁来治疗新生儿持续性肺高压，但随机对照性试验则推荐。
On the basis of the current lack of evidence, the use of magnesium sulphate cannot be recommended in the treatment of PPHN. Randomised controlled trials are recommended.
由于目前缺乏证据，并不推荐使用硫酸镁来治疗新生儿持续性肺高压，但随机对照性试验则推荐。
应用推荐